Tamara Franklin - 12 Nov 2025 Form 4 Insider Report for Genpact LTD (G)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Nov 2025, 16:53:57 UTC
Prior SEC filing
27 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Tamara Franklin

Key filing fact

Tamara Franklin filed Form 4 for Genpact LTD (G) on 13 Nov 2025.

Key facts

  • This page summarizes Tamara Franklin's Form 4 filing for Genpact LTD (G).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Nov 2025, 16:53.

Change

  • Previous filing in this sequence was filed on 27 May 2025.
  • Current net transaction value: -$125,538.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001855053 Primary reporting owner

Franklin Tamara

Relationship
Director
Address
C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Tamara Franklin
Signature date
13 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

G transaction

Common Shares

Sale

Transaction value
$125,538
Shares
-2,750
Change %
-11%
Price
$45.65
Shares after
22,236
Date
12 Nov 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .